Reviva Pharmaceuticals Holdings, Inc.
RVPH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001742927
No open-market purchases or sales by Reviva Pharmaceuticals Holdings, Inc. insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $3.67K in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Reviva Pharmaceuticals Holdings, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 12 | 12 | 0 |
| Shares | 2.65M | 2.60M | −49.3K (−1.9%) |
| Value | $12.8M | $10.5M | −$2.23M (−17.5%) |
New holders (3)
Institutions that held Reviva Pharmaceuticals Holdings, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 26,635 | $108.0K | 0.00% |
| Bank of America Corp | 24,806 | $101.0K | 0.00% |
| HRT Financial LP | 13,453 | $54.0K | 0.00% |
Sold out (3)
Institutions that held Reviva Pharmaceuticals Holdings, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Tower Research Capital LLC (TRC) | 12,484 | $61.0K |
| Renaissance Technologies LLC | 11,250 | $55.0K |
| Davenport & Co LLC | 10,000 | $49.0K |